Innate Pharma (IPHA) Non-Current Deferred Revenue (2017 - 2025)
Innate Pharma (IPHA) posted Non-Current Deffered Revenue of $147,620 for the quarter ended Jun 30, 2026, down 76.8% from $637,293 a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Non-Current Deferred Revenue (2017 - 2025) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Non-Current Deffered Revenue came in at $3.19 million, up 378.7% from the prior year.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -24.4% (years ended Dec 2020 to Dec 2025).
- In prior years, Innate Pharma's Non-Current Deffered Revenue was $666,720 in the year ended Dec 31, 2024 (-89.5%), $6.34 million in the year ended Dec 31, 2023 (-8.2%), $6.91 million in the year ended Dec 31, 2022 (-51.6%) and $14.3 million in the year ended Dec 31, 2021 (+10.8%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Non-Current Deffered Revenue since the quarter ended Jun 30, 2023.
- On a year-over-year basis, Non-Current Deffered Revenue increased in 1 of the last four quarters, with growth averaging 38.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 3.08 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Dec 31, 2023 | 5.11 Mn |
| Jun 30, 2023 | 6.49 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Jun 30, 2022 | 8.71 Mn |
| Dec 31, 2021 | 28.78 Mn |
| Jun 30, 2021 | 32.85 Mn |
| Dec 31, 2020 | 40.19 Mn |
| Jun 30, 2020 | 23.05 Mn |
| Dec 31, 2019 | 45.19 Mn |
| Dec 31, 2018 | 77.90 Mn |
| Dec 31, 2017 | 103.90 Mn |
API Access
Innate Pharma Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();